Dr Patrick Lee Fraley, MD | |
2425 Dave Ward Dr Ste 1101, Conway, AR 72034-8686 | |
(501) 932-7600 | |
(501) 932-7603 |
Full Name | Dr Patrick Lee Fraley |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 20 Years |
Location | 2425 Dave Ward Dr Ste 1101, Conway, Arkansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376623165 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Baptist Health Medical Center- Conway | Conway, AR | Hospital |
Uams Medical Center | Little rock, AR | Hospital |
Conway Regional Health System | Conway, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Arkansas | 4082528955 | 1121 |
News Archive
United States-based firm Gordon Thomas Honeywell Governmental Affairs (GTH-GA) announced the launch of the Forensic DNA World Map Project (WMP), a new component to GTH-GA's popular DNAResource.com, which monitors developments in forensic DNA policy. GTH-GA's president, Tim Schellberg, made the announcement in Lyon, France during INTERPOL's 6th International DNA User's Conference.
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).
These days the U.S. Food and Drug Administration (FDA) is taking no chances when it comes to the safety of new drugs.
Albeit pregnancy is generally considered a significant risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and more severe coronavirus disease (COVID-19) outcomes, a recent study by a multinational team of researchers shows that symptoms are generally comparable between pregnant and non-pregnant cohorts of women – with the exception of gastrointestinal symptoms. This paper is currently available on the medRxiv* preprint server.
› Verified 4 days ago
Entity Name | University Of Arkansas For Medical Sciences |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
United States-based firm Gordon Thomas Honeywell Governmental Affairs (GTH-GA) announced the launch of the Forensic DNA World Map Project (WMP), a new component to GTH-GA's popular DNAResource.com, which monitors developments in forensic DNA policy. GTH-GA's president, Tim Schellberg, made the announcement in Lyon, France during INTERPOL's 6th International DNA User's Conference.
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).
These days the U.S. Food and Drug Administration (FDA) is taking no chances when it comes to the safety of new drugs.
Albeit pregnancy is generally considered a significant risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and more severe coronavirus disease (COVID-19) outcomes, a recent study by a multinational team of researchers shows that symptoms are generally comparable between pregnant and non-pregnant cohorts of women – with the exception of gastrointestinal symptoms. This paper is currently available on the medRxiv* preprint server.
› Verified 4 days ago
Entity Name | Jeffrey P Kirsch Md Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295958346 PECOS PAC ID: 0941378897 Enrollment ID: O20081006000577 |
News Archive
United States-based firm Gordon Thomas Honeywell Governmental Affairs (GTH-GA) announced the launch of the Forensic DNA World Map Project (WMP), a new component to GTH-GA's popular DNAResource.com, which monitors developments in forensic DNA policy. GTH-GA's president, Tim Schellberg, made the announcement in Lyon, France during INTERPOL's 6th International DNA User's Conference.
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).
These days the U.S. Food and Drug Administration (FDA) is taking no chances when it comes to the safety of new drugs.
Albeit pregnancy is generally considered a significant risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and more severe coronavirus disease (COVID-19) outcomes, a recent study by a multinational team of researchers shows that symptoms are generally comparable between pregnant and non-pregnant cohorts of women – with the exception of gastrointestinal symptoms. This paper is currently available on the medRxiv* preprint server.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Patrick Lee Fraley, MD Po Box 251420, Little Rock, AR 72225-1420 Ph: (501) 686-8000 | Dr Patrick Lee Fraley, MD 2425 Dave Ward Dr Ste 1101, Conway, AR 72034-8686 Ph: (501) 932-7600 |
News Archive
United States-based firm Gordon Thomas Honeywell Governmental Affairs (GTH-GA) announced the launch of the Forensic DNA World Map Project (WMP), a new component to GTH-GA's popular DNAResource.com, which monitors developments in forensic DNA policy. GTH-GA's president, Tim Schellberg, made the announcement in Lyon, France during INTERPOL's 6th International DNA User's Conference.
MacuSight, a developer of innovative therapeutics for the treatment of severe ocular diseases and conditions, today announced that it has received Fast Track designation from the United States Food and Drug Administration (FDA) for Perceiva, the company's proprietary ocular sirolimus product, for the treatment of diabetic macular edema (DME).
These days the U.S. Food and Drug Administration (FDA) is taking no chances when it comes to the safety of new drugs.
Albeit pregnancy is generally considered a significant risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and more severe coronavirus disease (COVID-19) outcomes, a recent study by a multinational team of researchers shows that symptoms are generally comparable between pregnant and non-pregnant cohorts of women – with the exception of gastrointestinal symptoms. This paper is currently available on the medRxiv* preprint server.
› Verified 4 days ago
Dr. Rafael Jorge Marrero, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2200 Ada Ave, Suite 202, Conway, AR 72034 Phone: 501-327-3929 Fax: 501-329-3816 | |
Dr. Collie Blevins Shaw, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2200 Ada Ave, Suite 202, Conway, AR 72034 Phone: 501-327-3929 Fax: 501-329-3816 |